Both sides of the aisle support making newer and larger investments in our Nation's infrastructure.
Greg Walden
The Public Record
Greg Walden is a former U.S. Representative from Oregon, serving in the House from 1999 to 2021. A member of the Republican Party, he represented Oregon's 2nd congressional district. During his tenure, Walden was known for his work on issues related to healthcare, telecommunications, and energy policy. He played a significant role in the passage of the 21st Century Cures Act, which aimed to accelerate medical product development and bring new innovations to patients more quickly.
I especially want to draw attention to H.R. 931, the Firefighter Cancer Registry Act of 2017, which requires Centers for Disease Control and Prevent to develop a voluntary registry of firefighter occupational information that can be linked…
This hearing is certainly an important first step in reviewing bills that are bipartisan, can benefit all of our constituents, and I certainly hope it will not be the last.
Providing emergency alert and warning information to the public before, during, and after incidents and disasters is a key component to our emergency system.
This bill would expand and codify the Stop, Observe, Ask, and Respond (SOAR) program at HHS.
I thank my colleague, Rep. Chris Collins for sponsoring this important legislation.
We are committed to seeing the alerting systems be both more effective and responsive to all communities, particularly those that have been historically underserved.
We need to make sure that Federal policy doesn't inhibit technological advancement.
Legislation offered by Rep. Robin Kelly, known as the Action for Dental Health Act of 2017, would help increase access to dental care.
I thank the chairman for her leadership on these and other issues involving communications.
The willingness of qualified volunteers to offer their services to those in need should not be deterred by the fear of liability actions being brought against them.
Emergency alerting has come a long way since it was established in 1951, the Integrated Public Alert and Warning System now reaches people via broadcast, cable, satellite, and mobile devices.
I want to commend Mr. Shimkus, who has gone up to the other hearing, I believe, for his work in transitioning America's laws over into the wireless world as well.
As we move forward, we want to make sure that our first responder community and the citizens that they serve and protect have access to the latest technologies.
I have to say that the information that we are being told, even The New York Times has characterized some of it as being misleading, and it is. When you say Oregonians are going to suddenly be thrown out, that is not true on preexisting…
I thank our colleagues who have worked so hard on this legislation to try and rescue these failing insurance markets. We learned yesterday, I think most of Iowa now will not have a single insurer left on the exchanges. If you are one of…
I thank the gentleman from Florida for not only raising this issue, but being a real partner in this legislation. I met with your Governor as well, who has been very helpful in the discussions. We believe that accounting for aging…
Today's hearing is a great opportunity for us to learn more about four bipartisan medical device bills that could potentially be included in this effort.
I thank the gentleman from Texas, the chairman, for holding this hearing and our witnesses for your testimony today.
I am committed to ensuring patient safety while minimizing regulatory burden.
H.R. 1652, the Over-the-Counter Hearing Aid Act, would require the FDA to issue regulations establishing a category of OTC hearing aids for adults with perceived mild to moderate hearing loss.
We meet today to once again discuss the FDA's vitally important user fee programs, as you all know.
I look forward to continued discussions with my colleagues in the House on other member priorities that could strengthen this important legislation.
The Energy and Commerce Committee is fully committed to a timely reauthorization of FDA's vitally important user fee programs.





